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Background
Antibodies against cyclic citrullinated peptid (anti-CCP)
and mutated citrullinated vimentin (anti-MCV) have been
extensively studied as an early diagnostic and prognostic
markers in rheumatoid arthritis (RA), however there is lit-
tle data available on the role of anti-MCV in Juvenile idi-
opathic arthritis (JIA).
Objectives
To detect significance of anti-MCV in children with JIA.
Materials and methods
We analysed 41 patients with newly diagnosed JIA (25 RF
negative polyarthritis, 10 oligoarthritis, 5 undifferentiated
and 1 psoriatic arthritis). To evaluate disease activity, clin-
ical (disease type, number of active and inactive joints)
and laboratory (CRP, ESR, TNF alfa, ANA titer, HLA B 27
antigen) data were recorded. The level of anti-MCV in the
sera of JIA patients and 21 controls (healthy chidren with
no family history of any rheumatological disease) was
measured using ELISA method (Orgenetic Diagnostica,
GbmH, Germany). For statistical analysis we used T test
and Mann-Whitney test.
Results
Although mean anti-MCV level in the JIA group was high-
ier (3.73 U/ml, range 2 – 10 U/ml), then in the control
group (3.14 U/ml, range 2 – 9 U/ml), these results are not
statistically singificant (p > 0.05). Evaluating disease activ-
ity, we found a positive correaltion of anti-MCV with CRP
(p < 0.05) and serum amiloid A (SAA) (p < 0.01) level.
SAA has a positive predictive value for anti-MCV.
Conclusion
Anti-MCV can't serve as an early JIA diagnosting marker.
There is a direct correlation between anti-MCV level and
acute inflammatory markers and anti-MCV can be used as
a disease activity marker.
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